Asahi Kasei Medical/AW Technologies TrachFlush System (Bildquelle: Asahi Kasei)
Düsseldorf, April 3, 2024 – AW Technologies and Asahi Kasei Medical, a core company in the health care division of the Japanese technology group Asahi Kasei, have entered into an exclusive distribution agreement for AW Technologies’ TrachFlush™ device in Japan. AW Technologies is currently undergoing the approval process for TrachFlush™ in Japan. The market launch is planned for the 2024 financial year.
Developed by AW Technologies based on an intensive care physician’s invention, TrachFlush is a medical device that reduces the discomfort of ventilated patients while reducing the workload of medical staff when suctioning the trachea. The TrachFlush supports the management of respiratory secretions (mucus) with a unique cuff pressure control system. With the push of a button, the TrachFlush deflates the cuff, uses the ventilator’s air pressure during an inspiratory cycle, and re-inflates the cuff before the cycle is completed.
TrachFlush received CE Mark in Europe in 2020 and FDA approval in the USA in 2023. In Japan, marketing and sales are now handled exclusively by Asahi Kasei Medical. Ken Shinomiya, President of Asahi Kasei Medical, said: “We are pleased to add TrachFlush to our critical care product offering. By leveraging our experience and know-how in the field of blood purification, we are convinced that this product offers a wide range of added value, such as: “We are very pleased to announce our partnership with Asahi Kasei Medical. This partnership is very important for AW Technologies, and Asahi Kasei Medical will play a very important role in our global expansion of TrachFlush. We believe TrachFlush will have a major impact in the intensive care unit – not only by preventing ventilator-associated pneumonia, but also by non-invasively preventing secretion buildup in the airways.”
To AW Technologies ApS
AW Technologies is a Danish medical technology company founded in 2018 that focuses on developing innovative airway management solutions for ventilated patients. For more information please visit www.trachflush.com and www.awtechnologies.dk
Zu Asahi Kasei Medical
Asahi Kasei Medical is a core company in the health care division of the Asahi Kasei Group. The blood purification business includes devices and systems for dialysis and therapeutic apheresis, and the bioprocessing business includes equipment for biotherapeutics manufacturing, biosafety testing services and CDMO activities for biologics. For more information, visit www.asahi-kasei.co.jp/medical/en/
Zur Asahi Kasei Corporation
The Asahi Kasei Corporation is a global technology group with three business areas: Materials, Homes and Health Care. The Materials business area includes fibers & textiles, petrochemicals, high-performance polymers and materials, consumer goods, battery separators and electronic devices. The Homes division offers building materials through to finished houses on the Japanese market. The health care sector includes pharmaceuticals, medical technology as well as devices and systems for acute and intensive care medicine. With more than 48,000 employees worldwide, the Asahi Kasei Group serves customers in more than 100 countries and achieved sales of 20.2 billion euros (2,726 billion yen) in the 2022 fiscal year (April 1, 2022 – March 31, 2023).
contact person
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17, 40221 Düsseldorf
Tel: +49 (0) 211-3399-2058
Mail: [email protected]
Press contact
financial relations GmbH
Henning Yes
Louisenstraße 97, 61348 Bad Homburg
Tel: +49 (0) 6172/ 27159 – 12
Mail: [email protected]
Image source: Asahi Kasei
Zur Asahi Kasei Corporation
The Asahi Kasei Corporation is a global technology group with three business areas: Materials, Homes and Health Care. The Materials business area includes fibers & textiles, petrochemicals, high-performance polymers, high-performance materials, consumer goods, battery separators and electronic devices. The Homes division offers building materials through to finished houses on the Japanese market. The health care sector includes pharmaceuticals, medical technology as well as devices and systems for acute and intensive care medicine. With more than 46,000 employees worldwide, the Asahi Kasei Group serves customers in more than 100 countries and achieved sales of 20 billion euros (2,726 billion yen) in the 2022 fiscal year (April 1, 2022 – March 31, 2023).
“Creating for Tomorrow”. With this slogan, the Asahi Kasei Group refers to the common mission of all its companies to help people all over the world live and live better with sustainable products and technologies.
For more information, see:
www.asahi-kasei.com, www.asahi-kasei.eu and
Company contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Fringsstrasse 17
40221 Düsseldorf
+49 (0)211 3399-2058
Press contact
financial relations GmbH
Henning Yes
Louisenstraße 97
61348 Bad Homburg
+49 (0) 6172 27159 12